Klaricid Adult

Clarithromycin, the active ingredient in Klaricid Adult, is a macrolide antibiotic presented as an oral formulation for oral use. It treats bacterial infections in adult patients, including respiratory and skin infections. GNH USA supplies Klaricid Adult as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Clarithromycin is a macrolide antibiotic used to treat infections caused by susceptible bacteria. - Community‑acquired pneumonia: effective treatment of bacterial pneumonia in adults. - Acute bacterial sinusitis: eradicates the causative organisms and relieves sinus inflammation. - Acute bacterial exacerbation of chronic bronchitis: reduces bacterial load and improves respiratory symptoms. - Skin and soft tissue infections: combats susceptible skin pathogens and promotes healing. - Helicobacter pylori eradication regimens: part of combination therapy to eliminate H. pylori infection.

Clarithromycin may cause a range of adverse reactions.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Diarrhea: loose stools, sometimes watery. - Abdominal pain: cramping or discomfort in the stomach area. - Taste disturbance: altered or metallic taste perception.

Serious or Rare Side Effects: - Severe allergic reactions: rash, swelling, or anaphylaxis. - Clostridioides difficile‑associated diarrhea: severe colitis requiring medical attention. - QT interval prolongation: potential cardiac arrhythmias. - Hepatotoxicity: elevated liver enzymes or liver injury.

Before prescribing Klaricid Adult, consider the following safety measures. - Assess renal function: dose adjustment may be needed in renal impairment. - Monitor liver enzymes: watch for signs of hepatotoxicity during therapy. - Check for drug interactions: especially with agents that affect QT interval or CYP3A4 metabolism. - Avoid use in patients with known macrolide hypersensitivity: discontinue if allergic reaction occurs. - Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Clarithromycin interacts with several medicines; awareness of the interaction level guides management.

Major Interactions (Avoid): - Other macrolides (e.g., erythromycin): additive risk of QT prolongation. - Cisapride: may cause serious cardiac arrhythmias. - Pimozide: increased plasma concentrations leading to toxicity. - Theophylline: elevated levels can cause seizures or cardiac effects.

Moderate Interactions (Monitor Closely): - Warfarin: enhanced anticoagulant effect, monitor INR. - Statins (lovastatin, simvastatin): increased risk of myopathy, consider dose adjustment. - Carbamazepine: reduced clarithromycin exposure, may require efficacy monitoring.